Modeling the impact of supra-structural network nodes: The case of anonymous syringe sharing and HIV among people who inject drugs

Social Science Research

Volumn 41, Issue 3, 2012, Pages 624-636

  Richardson, Lindsey ^a   Grund, Thomas ^a,b  

^a NUFFIELD COLLEGE   (United Kingdom)

^b ETH ZURICH   (Switzerland)

Author keywords

Calibrated agent based model; Disease diffusion; HIV transmission; Quasi anonymous transmission; Shooting gallery; Syringe sharing

Indexed keywords

EID: 84858293568     PISSN: 0049089X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ssresearch.2011.12.004     Document Type: Article

References (71)

1. Abdala N., Stephens P.C., Griffith B.P., Heimer R. Survival of HIV-1 in syringes. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1999, 20:73-80.
2. Abu-Raddad L.J., Longini I.M. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 2008, 22:1055-1061.
3. Aceijas C., Stimson G.V., Hickman M., Rhodes T. United Nations reference group on HIV/AIDS prevention and care among IDU in developing and transitional countries, 2004. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004, 18:2295-2303.
4. Alam S.J., Meyer R., Ziervogel G., Moss S. The impact of HIV/AIDS in the context of socioeconomic stressors: an evidence-driven approach. Journal of Artificial Societies and Social Simulation 2007, 10:7.
5. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. Journal of Acquired Immune Deficiency Syndromes 1990, 3:1010-1016.
6. Atkinson J. A simulation model of the dynamics of HIV transmission in intravenous drug users. Computers and Biomedical Research 1996, 29:338-349.
7. Berkman L.F., Glass T., Brissette I., Seeman T.E. From social integration to health: Durkheim in the new millennium. Social Science & Medicine 2000, 51:843-857.
8. Chiasson R.E., Moss A.R., Onishi R., Osmond D., Carlson J.R. Human immunodeficiency virus in heterosexual intravenous drug users in San Francisco. American Journal of Public Health 1987, 77:169-172.
9. Chitwood D.D., McCoy C.B., Inciardi J.A., McBride D.C., Comerford M., Trapido E., McCoy V., Page J.B., Grivvin J., Fletcher M.A., Ashman M.A. HIV seropositivity of needles from shooting galleries in south Florida. American Journal of Public Health 1990, 80:150-152.
10. Cioffi-Revilla C. A methodology of complex social simulations. Journal of Artificial Social Societies and Social Simulation 2010, 13:7.
11. Cui, Q., Wang, J., Tan, J., Li, J. Yang, K., 2009. Exploring HIV/AIDS epidemic complex network of IDU using ABM and GIS. In: Chinese control and decision conference, 17-19 June, pp. 1090-1095.
12. Curtis R., Friedman S.R., Neaigus A., Jose B., Goldstein M., Ildefonso G. Street-level drug markets: network structure and HIV risk. Social Networks 1995, 17:229-249.
13. Des Jarlais D.C., Friedman S.R. Shooting galleries and AIDS: infection probabilities and 'tough' policies. American Journal of Public Health 1990, 80:142-144.
14. Des Jarlais D.C., Friedman S.R., Stoneburner R.L. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Reviews of Infectious Diseases 1988, 10:151-157.
15. Des Jarlais D.C., Friedman S.R., Novick D.M., Sotheran J.L., Thomas P., Yancovitz S.R., Mildvan D., Weber J., Kreek M.J., Maslansky R., Bartelme S., Spira T., Marmor M. HIV-1 infection among intravenous drug users in Manhattan, New York, City, from 1977 through 1987. Journal of the American Medical Association 1989, 261:1008-1012.
16. Friedman, S.R., 1995. Promising social network research results and suggestions for a research agenda. In: Needle, R.H., Coyle, S.L., Genser, S.G., Trotter, R.T. (Eds.), Social Networks, Drug Abuse, and HIV Transmission. NIDA Research Monograph 151, pp. 196-215.
17. Friedman S.R., Neaigus A., Jose B., Curtis R., Goldstein M., Ildefonso G., Rothernberg R.B., Des Jarlais D.C. Sociometric risk networks and risk for HIV infection. American Journal of Public Health 1997, 87:1289-1296.
18. Friedman S.R., Curtis R., Neaigus A., Jose B., Des Jarlais D.C. Social Networks, Drug Injectors' Lives and HIV/AIDS 1999, Kluwer Academic/Plenum, New York.
19. Friedman S.R., Kottiri B., Neaigus A., Curtis R., Vermund S.H., Des Jarlais D.C. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. American Journal of Epidemiology 2000, 152:913-922.
20. Friedman S.R., Bolyard M., Mateu-Gelabert P., Goltzman P., Pawlowicz M.P., Singh D.Z., Touze G., Rossi D., Maslow C., Sandoval M., Flom P.L. Some data-driven reflections on priorities in AIDS network research. AIDS Behavior 2007, 11:641-651.
21. Gilbert N. Agent-Based Models 2008, Sage, London.
22. Goodreau S.M. Assessing the effects of human mixing patterns on human immunodeficiency virus - 1: Interhost phylogenetics through social network simulation. Genetics 2006, 172:2033-2045.
23. Greenhalgh D., Hay G. Mathematical modeling of the spread of HIV/AIDS amongst injecting drug users. IMA Journal of Mathematics Applied in Medicine & Biology 1997, 14:11-38.
24. Gyarmathy V.A., Neiagus A. The effect of personal network exposure on injecting equipment sharing among IDUs in Budapest, Hungary. Connections 2006, 27:25-38.
25. Hall H.I., Song R., Rhodes P., Prejean J., An Q., Lee L.M., Karon J., Brookmeyer R., Kaplan E.H., McKenna M.T., Janssen R.S. Estimation of HIV incidence in the United States. Journal of the American Medical Association 2008, 300:520-529. (for the HIV Incidence Surveillance Group).
26. Hedström P. Dissecting the Social 2006, Cambridge University Press, Cambridge.
27. Hoffer L.D., Bobashev G., Morris R.J. Researching a local heroin market as a complex adaptive system. American Journal of Community Psychology 2009, 44:273-286.
28. Iannelli M.F., Milner A., Pugliese A., Gonzo M. The HIV/AIDS epidemics among drug injectors: a study of contact structure through a mathematical model. Mathematical Biosciences 1997, 139:25-58.
29. Janssen M.A., Ostrom E. Empirically based, agent-based models. Ecology and Society 2006, 11(2):37.
30. Kaplan E.H. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Reviews of Infectious Diseases 1989, 11:289-298.
31. Kiss I.Z., Green D.M., Kao R.R. The effect of network mixing patterns on epidemic dynamics and the efficacy of disease contact tracing. Journal of the Royal Society Interface 2008, 5:791-799.
32. Klein H., Levy J.A. Shooting gallery users and HIV risk. Journal of Drug Issues 2003, 33:751-767.
33. Klovdah A.S., Graviss E.A., Yaganehdoost A., Ross M.W., Wanger A., Adams G.J., Musser J.M. Networks and tuberculosis: an undetected community outbreak involving public places. Social Science & Medicine 2001, 52:681-694.
34. Klovdahl A.S. Social networks and the spread of infectious diseases: the AIDS example. Social Science & Medicine 1985, 21:1203-1216.
35. Kottiri B.J., Friedman S.R., Neaigus A., Curtis R., Des Jarlais D.C. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes 2002, 30:95-104.
36. Kretzschmar M., Wiessing L.G. Modeling the spread of HIV in social networks of injecting drug users. AIDS 1998, 12:801-811.
37. Latkin C., Mandell W., Vlahov D., Knowlton A., Oziemkowska M., Celentano D. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance. Social Networks 1995, 17:219-228.
38. Latkin C.A., Kuramoto S.J., Davey-Rothwell M.A., Tobin K.E. Social norms, social networks, and HIV risk behavior among injection drug users. AIDS Behavior 2010, 14:1159-1168.
39. Laufer F.N. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes 2001, 28:273-278.
40. Longini I.M., Clark W.S., Haber M., Horsburgh R. The stages of HIV infection: waiting times and infection transmission probabilities. Mathematical and Statistical Approaches to AIDS Epidemiology 1990, 111-137. Springer-Verlag, New York. C. Castillo-Chaves (Ed.).
41. Macy M.R., Willer R. From factors to actors: computational sociology and agent-based modeling. Annual Review of Sociology 2002, 28:143-166.
42. Morris M. Data driven network models for the spread of infectious disease. Epidemic Models: Their Structure and Relation to Data 1995, 302-322. Cambridge University Press, Cambridge. D. Mollison (Ed.).
43. Morris M., Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997, 11:641-648.
44. Morris M., Podhisita C., Wawer M.J., Handcock M.S. Bridge populations in the spread of HIV/AIDS in Thailand. AIDS 1996, 10:1265-1271.
45. Moss S. Alternative approaches to the empirical validation of agent-based models. Journal of Artificial Societies and Social Simulation 2008, 11:5.
46. Neaigus A., Friedman S.R., Curtis R., Des Jarlais D.C., Furst R.T., Jose B., Mota P., Stepherson B., Sufian M., Ward T., Wright J.W. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Social Science & Medicine 1994, 38:67-78.
47. Neaigus, A., Friedman, S.R., Goldstein, M.R., Ildefonso, G., Curtis, R., Jose, B., 1995. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. In: Needle, R.H., Coyle, S.L., Genser, S.G., Trotter, R.T. (Eds.), Social Networks, Drug Abuse, and HIV Transmission. NIDA Research Monograph 151, pp. 20-37.
48. Ouellet L., Huo D., Bailey S.L. HIV risk practices among needle exchange users and nonusers in Chicago. Journal of Acquired Immune Deficiency Syndromes 2004, 37:1187-1196.
49. Peterson D., Willard K., Altmann M., Gatewood L., Davidson G. Monte carlo simulation of HIV infection in an intravenous drug user community. Journal of Acquired Immune Deficiency Syndromes 1990, 3:1086-1095.
50. Poteete A., Janssen M.A., Ostrom E. Working Together: Collective Action, The Commons, and Multiple Methods in Practice 2010, Princeton University Press, Princeton, NJ.
51. Potterat J.J., Rothenberg R.B., Muth S.Q. Network structural dynamics and infectious disease propagation. International Journal of STD & AIDS 1999, 10:182-185.
52. Pouget E.R., Deren S., Fuller C.M., Blaney S., McMahon J.M., Kang S.Y., Tortu S., Andia J.F., Des Jarlais D.C., Vlahov D. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes 2005, 39:471-477.
53. Price, R.K., Cottler, L.B., Mager, D., Murray, K.S., 1995. Injecting drug use, characteristics of significant others, and HIV-risk behaviors. In: Needle, R.H., Coyle, S.L., Genser, S.G., Trotter, R.T. (Eds.), Social Networks, Drug Abuse, and HIV Transmission. NIDA Research Monograph 151, pp. 38-59.
54. Raboud J.M., Boily M.C., Rajeswaran J., O'Shaughnessy M.V., Schechter M.T. The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study. Journal of Urban Health 2003, 80:302-320.
55. Rahmandad H., Sterman J. Heterogeneity and network structure in the dynamics of diffusion: comparing agent-based and differential equation models. Management Science 2008, 54:998-1014.
56. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 2005, 61:1026-1044.
57. Rogers E.M. Diffusion of Innovations 2003, Free Press, New York, NY. fifth ed.
58. Rothenberg, R.B., Potterat, J.J., Wookhouse, D.E., Muth, S.Q., Darrow, W.W., Klovdahl, A.S., 1995. Social networks in disease transmission: the Colorado Springs study. In: Needle, R.H., Coyle, S.L., Genser, S.G., Trotter, R.T. (Eds.), Social Networks, Drug Abuse, and HIV Transmission. NIDA Research Monograph 151, pp. 3-19.
59. Rothenberg R.B., Baldwin J., Trotter R., Muth S. The risk environment for HIV transmission: results from the Atlanta and Flagstaff network studies. Journal of Urban Health 2001, 78:419-432.
60. Sallach D.L., Macal C.M. Introduction: the simulation of social agents. Social Science Computer Review 2001, 19:245-248.
61. Sherman S.G., Latkin C.A., Gielen A.C. Social factors related to syringe sharing among injecting partners: a focus on gender. Substance Use & Misuse 2001, 36:2113-2136.
62. Tyler K. Social network characteristics and risky sexual and drug related behaviors among homeless young adults. Social Science Research 2008, 37:673-685.
63. UNAIDS Report on the Global AIDS Epidemic 2010, UNAIDS, Geneva.
64. Valente T.W. Network models and methods for studying the diffusion of innovations. Models and Methods in Social Network Analysis 2005, Cambridge University Press, New York, NY. P.J. Carrington, J. Scott, S. Wasserman (Eds.).
65. Volz E.M., Frost S.D., Rothenberg R., Meyers L.A. Epidemiological bridging by injection drug use drives an early HIV epidemic. Epidemics 2010, 2:155-164.
66. Volz E.M., Miller J.C., Galvani A., Ancel Meyers L. Effects of heterogeneous and clustered contact patterns on infectious disease dynamics. PLoS Computational Biology 2011, 7:e1002042.
67. Watts C.H., May R.M. The influence of concurrent partnerships on the dynamics of HIV/AIDS. Mathematical Bioscience 1992, 108:89-104.
68. Wilensky, U., 1999. NetLogo. Center for Connected Learning and Computer-Based Modeling, Northwestern University, Evanston, IL. http://ccl.northwestern.edu/netlogo/.
69. Windrum P., Fagiolo G., Moneta A. Empirical validation of agent-based models: alternatives and prospects. Journal of Artificial Societies and Social Simulation 2007, 10:8.
70. Wood E., Tyndall M.W., Spittal P.M., Li K., Kerr T., Hogg R.S., Montaner J.S., O'Shaughnessy M.V., Schechter M.T. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. Canadian Medical Association Journal 2001, 165:405-410.
71. Zaric G. Random vs. nonrandom missing in network epidemic models. Health Care Management Science 2002, 5:147-155.